Grail, Inc. GRAL Stock Forecast
AI-powered price prediction and analysis for Grail, Inc. · Alpha · vs marketSwitch to Total
See GRAL's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.
Price Chart
Key Statistics
About Grail, Inc.
Grail, Inc. (GRAL) operates within the Industrial Applications and Services sector, specifically in the Services-Medical Laboratories industry.
Latest News
Where GRAL sits on the market map
Services-Medical Laboratories Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | AI Signal | Market Cap | P/E |
|---|---|---|---|
| GRAL Grail, Inc. | $6.23B | – | |
| NTRA Natera, Inc. | $54.62B | – | |
| LH Labcorp Holdings Inc. | $28.74B | 29.0x | |
| DGX Quest Diagnostics Inc | $27.18B | 24.6x | |
| GH Guardant Health, Inc. | $23.48B | – | |
| CAI Caris Life Sciences, Inc. | $9.70B | 7.2x | |
| RDNT Radnet, Inc. | $5.78B | – | |
| BLLN Billiontoone, Inc. | $5.21B | 380.8x | |
| CDNA Caredx, Inc. | $4.52B | 43.9x | |
| VCYT Veracyte, Inc. | $3.94B | 43.0x | |
| CELC Celcuity Inc. | $3.38B | – | |
| FTRE Fortrea Holdings Inc. | $2.02B | – | |
| PSNL Personalis, Inc. | $1.68B | – | |
| FRNM Freenome, Inc. | $1.23B | – | |
| LMRI Lumexa Imaging Holdings, Inc. | $1.08B | – | |
| CSTL Castle Biosciences Inc | $1.07B | – | |
| FLGT Fulgent Genetics, Inc. | $533M | – | |
| BDSX Biodesix Inc | $222M | – | |
| XGN Exagen Inc. | $203M | – | |
| BNR Burning Rock Biotech Ltd | $117M | – | |
| SERA Sera Prognostics, Inc. | $78M | – | |
| MDXH Mdxhealth Sa | $18M | – | |
| AMS American Shared Hospital Services | $8M | – | |
| ACON Aclarion, Inc. | $5M | – | |
| ADVB Advanced Biomed Inc. | $3M | – | |
| BGLC Bionexus Gene Lab Corp | $3M | – | |
| RNLXY Renalytix Plc | N/A | – |
FAQ
Is Grail, Inc. a good stock to buy?
Our AI analyzes Grail, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.
How accurate are Grail, Inc. predictions?
For GRAL, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -45.0%, measured on 254 forecast dates between 2024-08-14 and 2026-08-06 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -24.0%, measured on 296 forecast dates between 2024-08-14 and 2026-10-05. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are forecasts updated?
Grail, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 4, 2026.
Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Grail, Inc.? View full institutional-grade analysis on Intratio →
AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.